Matthew Norkunas Generation Bio Co. (GBIO) insider trading activity

Matthew Norkunas is CHIEF FINANCIAL OFFICER of Generation Bio Co.. Currently has a direct ownership of 57,348 shares of GBIO, which is worth approximately $68,244. The most recent transaction as insider was on Oct 15, 2024, when has been sold 984 shares (Common Stock) at a price of $2.42 per share, resulting in proceeds of $2,381. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 57.3K

4.3% 3M change

43.61% 12M change

Total Value Held $68,244

Matthew Norkunas Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 15 2024	SELL Payment of exercise price or tax liability	$2,381 $2.42 p/Share	984 Reduced 1.69%	57,348 Common Stock
Oct 15 2024	BUY Exercise of conversion of derivative security	-	3,347 Added 5.47%	57,840 Common Stock
Jul 15 2024	SELL Payment of exercise price or tax liability	$2,883 $2.93 p/Share	984 Reduced 1.76%	54,985 Common Stock
Jul 15 2024	BUY Exercise of conversion of derivative security	-	3,347 Added 5.69%	55,477 Common Stock
Apr 15 2024	SELL Payment of exercise price or tax liability	$3,640 $3.7 p/Share	984 Reduced 1.84%	52,622 Common Stock
Apr 15 2024	BUY Exercise of conversion of derivative security	-	3,347 Added 5.93%	53,114 Common Stock
Jan 15 2024	SELL Payment of exercise price or tax liability	$10,462 $1.91 p/Share	5,478 Reduced 9.83%	50,259 Common Stock
Jan 15 2024	BUY Exercise of conversion of derivative security	-	15,805 Added 23.72%	50,840 Common Stock
Oct 15 2023	SELL Payment of exercise price or tax liability	$8,667 $3.24 p/Share	2,675 Reduced 6.28%	39,932 Common Stock
Oct 15 2023	BUY Exercise of conversion of derivative security	-	9,111 Added 18.39%	40,424 Common Stock
Jul 15 2023	SELL Payment of exercise price or tax liability	$16,083 $5.08 p/Share	3,166 Reduced 8.64%	33,496 Common Stock
Jul 15 2023	BUY Exercise of conversion of derivative security	-	10,785 Added 23.83%	34,479 Common Stock
Apr 15 2023	SELL Payment of exercise price or tax liability	$9,823 $4.5 p/Share	2,183 Reduced 7.78%	25,877 Common Stock
Apr 15 2023	BUY Exercise of conversion of derivative security	-	7,437 Added 20.95%	28,060 Common Stock
Jan 15 2023	SELL Payment of exercise price or tax liability	$13,147 $5.1 p/Share	2,578 Reduced 11.11%	20,623 Common Stock
Jan 15 2023	BUY Exercise of conversion of derivative security	-	7,438 Added 24.28%	23,201 Common Stock
Oct 15 2022	SELL Payment of exercise price or tax liability	$12,252 $5.61 p/Share	2,184 Reduced 12.17%	15,763 Common Stock
Oct 15 2022	BUY Exercise of conversion of derivative security	-	7,438 Added 29.3%	17,947 Common Stock
Jul 15 2022	SELL Payment of exercise price or tax liability	$31,355 $7.18 p/Share	4,367 Reduced 29.36%	10,509 Common Stock
Jul 15 2022	BUY Exercise of conversion of derivative security	-	14,876 Added 50.0%	14,876 Common Stock

Matthew Norkunas

CHIEF FINANCIAL OFFICER

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GBIO shares.

Notify only if

Value

Insider Trading

Get notified when an Generation Bio Co. insider buys or sells GBIO shares.

Notify only if

Operation

Value

Type

News

Receive news related to Generation Bio Co.

Track Activities on GBIO

Account